Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide MDI vs systemic steroid in acute COPD exacerbation
TCTR20220926002Phase 4Terminated
- Sponsor
- Department of Emergency Medicine
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Department of Emergency Medicine. Started Aug 2022; status: terminated.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on TCTR20220926002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220926002.